HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential competitive inhibition of a cell surface protease on normal epithelial cells and carcinoma cells of the colon.

Abstract
The cell surfaces of normal colonic epithelial cells and colonic carcinoma cells both possess a protease referred to as guanidinobenzoatase (GB). Previous studies have shown that these cells possess two distinct isoenzymic forms of GB which could be distinguished by their selective recognition of cytoplasmic protein inhibitors of GB. In the present study we have used competitive inhibitors of GB to demonstrate the differential inhibition of the GB on normal colonic epithelial cells whilst the GB on colonic carcinoma cell surfaces remains active. The enzymic status of GB on these cells has been determined by challenging the treated cells in frozen sections with a second fluorescent inhibitor, followed by fluorescence microscopic analysis.
AuthorsF S Steven, M Anees, I C Talbot
JournalAnticancer research (Anticancer Res) 1994 Sep-Oct Vol. 14 Issue 5A Pg. 2013-6 ISSN: 0250-7005 [Print] Greece
PMID7847843 (Publication Type: Journal Article)
Chemical References
  • Isoenzymes
  • Membrane Proteins
  • Aminacrine
  • Carboxylic Ester Hydrolases
  • guanidinobenzoate esterase
  • Endopeptidases
Topics
  • Aminacrine (metabolism)
  • Basement Membrane (enzymology)
  • Binding, Competitive
  • Carboxylic Ester Hydrolases (metabolism, pharmacology)
  • Colon (enzymology)
  • Colonic Neoplasms (enzymology)
  • Endopeptidases (metabolism, pharmacology)
  • Epithelium (enzymology)
  • Humans
  • Intestinal Mucosa (enzymology)
  • Isoenzymes (antagonists & inhibitors, metabolism)
  • Membrane Proteins (antagonists & inhibitors, metabolism)
  • Microscopy, Fluorescence
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: